Terminal micro-deletions in this chromosomal region or de novo mutation of DIP2A is associated with developmental delay [14], substantial susceptibility to autism spectrum disorder (ASD) [15–18], and dyslexia [19,20]. The gene discussed is DIP2A; the disease is autism spectrum disorder.